Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership384,843 shares
Latest Disclosed Value $ 1,485,494
Northern Trust Corp reports 4.42% increase in ownership of VYGR / Voyager Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 384,843 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $1,485,494 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 368,546 shares of Voyager Therapeutics, Inc.. This represents a change in shares of 4.42% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 384,843 16,297 4.42 1,485 2.56 0.0000
2026-02-17 2025-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 368,546 -26,205 -6.64 1,448 -21.43 0.0000
2025-11-14 2025-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 394,751 -9,731 -2.41 1,843 46.62 0.0001
2025-08-13 2025-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 404,482 -7,537 -1.83 1,258 -9.70 0.0002
2025-05-13 2025-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 412,019 -6,726 -1.61 1,393 -41.36 0.0002
2025-02-14 2024-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 418,745 12,374 3.05 2,374 -0.13 0.0003
2024-11-13 2024-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 406,371 32,210 8.61 2,377 -19.67 0.0004
2024-08-14 2024-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 374,161 -15,655 -4.02 2,960 -18.46 0.0005
2024-05-14 2024-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 389,816 74,850 23.76 3,629 36.53 0.0006
2024-02-13 2023-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 314,966 12,195 4.03 2,658 13.30 0.0005
2023-11-13 2023-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 302,771 6,651 2.25 2,346 -30.80 0.0005
2023-08-11 2023-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 296,120 210,133 244.38 3,391 412.08 0.0007
2023-05-15 2023-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 85,987 2,379 2.85 663 29.80 0.0001
2023-02-13 2022-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 83,608 6,608 8.58 510 11.84 0.0001
2022-11-14 2022-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 77,000 2,192 2.93 456 3.17 0.0001
2022-08-12 2022-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 74,808 -4,311 -5.45 442 -26.70 0.0001
2022-05-13 2022-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 79,119 1,683 2.17 603 188.52 0.0001
2022-02-08 2021-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 77,436 2,653 3.55 209 6.09 0.0000
2021-11-15 2021-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 74,783 -9,512 -11.28 197 -43.39 0.0000
2021-08-13 2021-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 84,295 -228,661 -73.06 348 -76.39 0.0001
2021-05-12 2021-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 312,956 -40,471 -11.45 1,474 -41.69 0.0003
2021-02-11 2020-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 353,427 -8,576 -2.37 2,528 -34.54 0.0005
2020-11-16 2020-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 362,003 -14,736 -3.91 3,862 -18.78 0.0008
2020-08-14 2020-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 376,739 32,508 9.44 4,755 51.00 0.0011
2020-05-14 2020-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 344,231 8,373 2.49 3,149 -32.79 0.0009
2020-02-14 2019-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 335,858 -195 -0.06 4,685 -18.99 0.0010
2019-11-13 2019-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 336,053 40,126 13.56 5,783 -28.21 0.0014
2019-08-13 2019-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 295,927 15,175 5.41 8,055 49.89 0.0019
2019-05-13 2019-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 280,752 5,712 2.08 5,374 107.89 0.0013
2019-02-12 2018-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 275,040 -9,945 -3.49 2,585 -52.05 0.0007
2018-11-14 2018-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 284,985 17,544 6.56 5,391 3.16 0.0013
2018-09-18 2018-06-30 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 267,441 67,063 33.47 5,226 38.80 0.0013
2018-08-14 2018-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 269,162 68,784 5,259
2018-05-09 2018-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 200,378 6,276 3.23 3,765 16.89 0.0010
2018-02-14 2017-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 194,102 40,606 26.45 3,221 1.93 0.0008
2017-11-13 2017-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 153,496 19,925 14.92 3,160 163.99 0.0008
2017-08-11 2017-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 133,571 28,222 26.79 1,197 -14.19 0.0003
2017-05-12 2017-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 105,349 -408 -0.39 1,395 3.56 0.0004
2017-02-13 2016-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 105,757 220 0.21 1,347 6.31 0.0004
2016-11-09 2016-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 105,537 -166 -0.16 1,267 9.13 0.0004
2016-08-12 2016-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 105,703 50,713 92.22 1,161 141.88 0.0004
2016-08-19 2016-03-31 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 54,990 0 0.00 480 -60.13 0.0002
2016-05-13 2016-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 54,990 480
2016-02-12 2015-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 54,990 54,990 1,204 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.